Atricure Inc. buy UBS Group AG
Start price
18.02.26
/
50%
€27.40
Target price
18.02.27
€46.43
Performance (%)
37.96%
Price
14.08.26
€37.20
Summary
This prediction is currently active. With a performance of 37.96% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 18.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | 10.714% | 10.714% |
| iShares Core DAX® | 0,44 % | 5,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) was given a new $55.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat